2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Benign Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
NIEMEYER, W | 1 |
HOLZER, H; SCHNEIDER, S; SCRIBA, P | 1 |
Hancock, CH; Hoffman, NW; Mondora, A; Tan, CT | 1 |
Griffin, JP; Krakoff, IH; McCormack, JJ; Newman, RA | 1 |
Bedikian, AY; Bodey, GP; Burgess, MA; Freireich, EJ | 1 |
Aisner, J; Budman, DA; Shulman, P; Sigman, LM; Van Echo, DA; Whitacre, MY | 1 |
6 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Benign Neoplasms
Article | Year |
---|---|
[Critical observations on therapy of malignancy with the cytostatic Bayer A 139 in otorhinolaryngological therapeutics].
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Cyclohexenes; Ear Neoplasms; Nasal Cavity; Neoplasms; Paranasal Sinus Neoplasms; Pharynx | 1958 |
[On the action of 2, 5-bis(2-methoxyethoxy)-3, 6-bis-ethylenimino-1, 4-benzoquinone (Bayer A 139) on the glycolysis of ascites tumor cells].
Topics: Animals; Antineoplastic Agents; Ascites; Aziridines; Benzoquinones; Carbohydrate Metabolism; Carbohydrates; Carcinoma, Ehrlich Tumor; Cyclohexenes; Glycolysis; Neoplasms | 1960 |
Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Central Nervous System Diseases; Child; Child, Preschool; Cyclohexenes; Drug Evaluation; Female; Hodgkin Disease; Humans; Infant; Leukemia; Male; Neoplasms | 1984 |
Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cyclohexenes; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1982 |
Phase I study of aziridinylbenzoquinone (NSC 182986).
Topics: Adult; Aged; Anemia; Aziridines; Azirines; Benzoquinones; Bone Marrow; Cyclohexenes; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Stomatitis; Thrombocytopenia; Vomiting | 1981 |
Phase I trial of 5-day continuous infusion aziridinylbenzoquinone (AZQ, diazaquone, NSC 182968).
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cyclohexenes; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1986 |